28139511|t|Evaluation of Outpatient Antibiotic Use in Beijing General Hospitals in 2015
28139511|a|Medical misuse of antibiotic s is associated with the acquisition and spread of antibiotic resistance, resulting in a lack of effective drugs and increased health-care cost. Nevertheless, inappropriate antibiotic use in China remains common and the situation requires urgent improvement. Here, we analyzed the prescriptions of antibiotics and evaluated the rationality of antibiotic use among outpatients in Beijing general hospitals during 2015. We collected basic medical insurance claim data from January 1, 2015 to December 31, 2015 in 507 general hospitals of Beijing. A descriptive analysis of outpatient antibiotic prescribing was performed. The Anatomical Therapeutic Chemical Classification/defined daily doses system was used to evaluate the rationality of antibiotic use. Over the study, an estimated 721,930, 613,520, and 822,480 antibiotics were dispensed in primary, secondary, and tertiary general hospitals corresponding to 5.09%, 5.06%, and 2.53% of all prescriptions, respectively. Antibiotic combinations represented 2.95%, 7.74%, and 10.18% of the total antibiotic prescriptions, respectively. Expenditure for the top twenty antibiotic s in primary, secondary, and tertiary general hospitals was RMB 42.92, 65.89, and 83.26 million Yuan, respectively. Cephalosporins were the most frequently prescribed class of antibiotic in clinical practice. The antibiotic s used inappropriately included azithromycin enteric-coated capsules, compound cefaclor tablets and nifuratel nysfungin vaginal soft capsules in primary hospitals, amoxicillin and clavulanate potassium dispersible tablets (7:1) and cefonicid sodium for injection in secondary hospitals, cefminox sodium for injection and amoxicillin sodium and sulbactam sodium for injection in tertiary hospitals. Antibiotic use in Beijing general hospitals is generally low; however, inappropriate antibiotic use still exists. Inappropriately used antibiotic s should be subject to rigorous control and management, and public policy initiatives are required to promote the judicious use of antibiotic s.
28139511	0	10	Evaluation	T058	UMLS:C0220825
28139511	25	35	Antibiotic	T103	UMLS:C0003232
28139511	43	50	Beijing	T082	UMLS:C4042832
28139511	51	68	General Hospitals	T092	UMLS:C0020008
28139511	77	84	Medical	T058	UMLS:C0199168
28139511	85	91	misuse	T033	UMLS:C0549649
28139511	95	105	antibiotic	T103	UMLS:C0003232
28139511	157	178	antibiotic resistance	T038	UMLS:C1326848
28139511	213	218	drugs	T103	UMLS:C0013227
28139511	279	289	antibiotic	T103	UMLS:C0003232
28139511	297	302	China	T082	UMLS:C0008115
28139511	374	382	analyzed	T062	UMLS:C0936012
28139511	387	400	prescriptions	T170	UMLS:C0033081
28139511	404	415	antibiotics	T103	UMLS:C0003232
28139511	420	429	evaluated	T058	UMLS:C0220825
28139511	449	459	antibiotic	T103	UMLS:C0003232
28139511	485	492	Beijing	T082	UMLS:C4042832
28139511	493	510	general hospitals	T092	UMLS:C0020008
28139511	543	560	medical insurance	T058	UMLS:C0021689
28139511	621	638	general hospitals	T092	UMLS:C0020008
28139511	642	649	Beijing	T082	UMLS:C4042832
28139511	653	664	descriptive	T170	UMLS:C0678257
28139511	665	673	analysis	T062	UMLS:C0936012
28139511	688	698	antibiotic	T103	UMLS:C0003232
28139511	730	803	Anatomical Therapeutic Chemical Classification/defined daily doses system	T170	UMLS:C3540695
28139511	816	824	evaluate	T058	UMLS:C0220825
28139511	844	854	antibiotic	T103	UMLS:C0003232
28139511	869	874	study	T062	UMLS:C2603343
28139511	919	930	antibiotics	T103	UMLS:C0003232
28139511	936	945	dispensed	T058	UMLS:C1880359
28139511	982	999	general hospitals	T092	UMLS:C0020008
28139511	1048	1061	prescriptions	T170	UMLS:C0033081
28139511	1151	1161	antibiotic	T103	UMLS:C0003232
28139511	1162	1175	prescriptions	T170	UMLS:C0033081
28139511	1222	1232	antibiotic	T103	UMLS:C0003232
28139511	1271	1288	general hospitals	T092	UMLS:C0020008
28139511	1349	1363	Cephalosporins	T103	UMLS:C3536856
28139511	1409	1419	antibiotic	T103	UMLS:C0003232
28139511	1423	1440	clinical practice	T058	UMLS:C0008949
28139511	1446	1456	antibiotic	T103	UMLS:C0003232
28139511	1489	1501	azithromycin	T103	UMLS:C0052796
28139511	1502	1525	enteric-coated capsules	T103	UMLS:C0039226
28139511	1527	1544	compound cefaclor	T103	UMLS:C0007537
28139511	1545	1552	tablets	T103	UMLS:C0039225
28139511	1557	1576	nifuratel nysfungin	T103	UMLS:C0028070
28139511	1577	1598	vaginal soft capsules	T103	UMLS:C1273013
28139511	1610	1619	hospitals	T092	UMLS:C0019994
28139511	1621	1632	amoxicillin	T103	UMLS:C0002645
28139511	1637	1658	clavulanate potassium	T103	UMLS:C0137997
28139511	1659	1678	dispersible tablets	T103	UMLS:C1273630
28139511	1710	1719	injection	T103	UMLS:C1272883
28139511	1733	1742	hospitals	T092	UMLS:C0019994
28139511	1744	1759	cefminox sodium	T103	UMLS:C1529767
28139511	1764	1773	injection	T103	UMLS:C1272883
28139511	1778	1796	amoxicillin sodium	T103	UMLS:C0887551
28139511	1801	1817	sulbactam sodium	T103	UMLS:C0282355
28139511	1822	1831	injection	T103	UMLS:C1272883
28139511	1844	1853	hospitals	T092	UMLS:C0019994
28139511	1855	1865	Antibiotic	T103	UMLS:C0003232
28139511	1873	1880	Beijing	T082	UMLS:C4042832
28139511	1881	1898	general hospitals	T092	UMLS:C0020008
28139511	1940	1950	antibiotic	T103	UMLS:C0003232
28139511	1990	2000	antibiotic	T103	UMLS:C0003232
28139511	2132	2142	antibiotic	T103	UMLS:C0003232